Chemotherapeutic agent

This page covers all Chemotherapeutic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Topoisomerase II.

Targets

Topoisomerase II

Phase 3 pipeline (6)

• induction chemotherapy · Zhejiang Cancer Hospital · Oncology
  Induction chemotherapy involves administering high-dose chemotherapy to kill cancer cells before a main treatment, such as surgery or radiation.
• TLC599 · Taiwan Liposome Company · Oncology
  TLC599 is a liposomal formulation of a chemotherapeutic agent.
• Chemotheraoy along · Fujian Medical University · Oncology
  Chemotheraoy along works by inhibiting cell division in rapidly proliferating cancer cells.
• Tri-weekly cisplatin with RT · Korea Cancer Center Hospital · Oncology
  Cisplatin works by damaging DNA and preventing cancer cells from dividing and growing.
• Oral chemotherapy · All India Institute of Medical Sciences · Oncology
  This oral chemotherapy drug works by interfering with DNA replication and cell division.
• Short Course Adjuvent Chemotherapy · Trans Tasman Radiation Oncology Group · Oncology
  Short Course Adjuvent Chemotherapy involves administering a limited course of chemotherapy to enhance the effectiveness of radiation therapy.